Trends in Bisphosphonate Initiation Within an Integrated Healthcare Delivery System
The authors observed a marked shift toward treatment of higher-risk subsets of younger postmenopausal women (with prior fracture and/or with osteoporosis), and away from women at lower risk.
Impact of a Medicare MTM Program: Evaluating Clinical and Economic Outcomes
A pharmacist-led Medicare Medication Therapy Management program can improve clinical outcomes in Medicare beneficiaries without an increase in medication costs.